Mpox update – August 2024
By Catherine Eckford (European Pharmaceutical Review)
Innovative pharma-government partnership to enhance UK clinical trials
By Catherine Eckford (European Pharmaceutical Review)
Novartis collaboration to innovate subcutaneous drug delivery
By Catherine Eckford (European Pharmaceutical Review)
AstraZeneca investment to increase biologic capacity in Sweden
By Catherine Eckford (European Pharmaceutical Review)
Regulating therapies for rare diseases – recent approvals
By Catherine Eckford (European Pharmaceutical Review)
Alzheimer’s drug development roundup – July 2024
By Catherine Eckford (European Pharmaceutical Review)